These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12409429)

  • 21. Survey of Bacteroides fragilis group susceptibility patterns in Canada.
    Bourgault AM; Lamothe F; Hoban DJ; Dalton MT; Kibsey PC; Harding G; Smith JA; Low DE; Gilbert H
    Antimicrob Agents Chemother; 1992 Feb; 36(2):343-7. PubMed ID: 1605600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of resistance to clindamycin in Bacteroides fragilis group isolates.
    Oteo J; Aracil B; Alós JI; Gómez-Garcés JL
    J Antimicrob Chemother; 2000 May; 45(5):691-3. PubMed ID: 10797095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience.
    Nagy E; Urbán E; Nord CE;
    Clin Microbiol Infect; 2011 Mar; 17(3):371-9. PubMed ID: 20456453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain.
    Betriu C; Culebras E; Gómez M; López F; Rodríguez-Avial I; Picazo JJ
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2686-90. PubMed ID: 18474575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology, antimicrobial susceptibility, pathogenicity, and significance of Bacteroides fragilis group organisms isolated at Los Angeles County-University of Southern California Medical Center.
    Appleman MD; Heseltine PN; Cherubin CE
    Rev Infect Dis; 1991; 13(1):12-8. PubMed ID: 2017610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence of carbapenem resistance in Bacteroides fragilis in China.
    Gao Q; Wu S; Xu T; Zhao X; Huang H; Hu F
    Int J Antimicrob Agents; 2019 Jun; 53(6):859-863. PubMed ID: 30831235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
    Snydman DR; Jacobus NV; McDermott LA
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4492-6. PubMed ID: 18838581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variation in the susceptibility of Bacteroides fragilis group isolates from six Chicago hospitals.
    Hecht DW; Osmolski JR; O'Keefe JP
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S357-60. PubMed ID: 8324147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial resistance in the Bacteroides fragilis group in faecal samples from patients receiving broad-spectrum antibiotics.
    Hansen KCM; Schwensen SAF; Henriksen DP; Justesen US; Sydenham TV
    Anaerobe; 2017 Oct; 47():79-85. PubMed ID: 28445776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and susceptibility of resistant Bacteroides fragilis group organisms to new beta-lactam antibiotics.
    Heseltine PN; Appleman MD; Leedom JM
    Rev Infect Dis; 1984; 6 Suppl 1():S254-9. PubMed ID: 6585882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
    Nagy E; Justesen US; Eitel Z; Urbán E;
    Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic sensitivity of the Bacteroides fragilis group in Denmark. Danish Study Group.
    Bremmelgaard A; Jansen JE; Justesen T; Gottschau A
    APMIS; 1993 Sep; 101(9):727-31. PubMed ID: 8240792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States.
    Aldridge KE; Gelfand M; Reller LB; Ayers LW; Pierson CL; Schoenknecht F; Tilton RC; Wilkins J; Henderberg A; Schiro DD
    Diagn Microbiol Infect Dis; 1994 Apr; 18(4):235-41. PubMed ID: 7924220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two cases of infections due to multidrug-resistant Bacteroides fragilis group strains.
    Katsandri A; Papaparaskevas J; Pantazatou A; Petrikkos GL; Thomopoulos G; Houhoula DP; Avlamis A
    J Clin Microbiol; 2006 Sep; 44(9):3465-7. PubMed ID: 16954304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility and prevalence of resistance genes in Bacteroides fragilis isolated from blood culture bottles in two tertiary care hospitals in Japan.
    Ogane K; Tarumoto N; Kodana M; Onodera A; Imai K; Sakai J; Kawamura T; Takeuchi S; Murakami T; Mitsutake K; Ikebuchi K; Maesaki S; Maeda T
    Anaerobe; 2020 Aug; 64():102215. PubMed ID: 32574601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.
    Appelbaum PC; Spangler SK; Jacobs MR
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1214-8. PubMed ID: 1929264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic resistance pattern of Bacteroides fragilis isolated from clinical and colorectal specimens.
    Jasemi S; Emaneini M; Ahmadinejad Z; Fazeli MS; Sechi LA; Sadeghpour Heravi F; Feizabadi MM
    Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):27. PubMed ID: 33892721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.
    Betriu C; Sánchez A; Gómez M; Palau ML; Picazo JJ
    J Antimicrob Chemother; 1999 Jan; 43(1):133-6. PubMed ID: 10381111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.
    Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Lee K; Kim JM; Chong Y
    Korean J Lab Med; 2009 Aug; 29(4):293-8. PubMed ID: 19726890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers.
    Turgeon P; Turgeon V; Gourdeau M; Dubois J; Lamothe F
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2276-9. PubMed ID: 7840557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.